SEC Form 4/A · accession 0001225208-16-029763
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Heino Lennartz
Officer — President Europe
Period of report
Feb 23, 2016
Accepted (ET)
Mar 14, 2016 · 3:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2016 | A | 3,212 | $59.64 | A | 30,707 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12. Original filing did not include 41 shares that were erroneously withheld for taxes. New number represents correct amount received.